高级搜索
葛彩云, 蔡红兵, 宋紫烨, 李蓁, 徐梦菲. HPV16-E6上调MIF对宫颈癌细胞增殖和凋亡的影响[J]. 肿瘤防治研究, 2018, 45(7): 468-474. DOI: 10.3971/j.issn.1000-8578.2018.17.1406
引用本文: 葛彩云, 蔡红兵, 宋紫烨, 李蓁, 徐梦菲. HPV16-E6上调MIF对宫颈癌细胞增殖和凋亡的影响[J]. 肿瘤防治研究, 2018, 45(7): 468-474. DOI: 10.3971/j.issn.1000-8578.2018.17.1406
GE Caiyun, CAI Hongbing, SONG Ziye, LI Zhen, XU Mengfei. HPV16-E6 Influences Growth and Apoptosis of Cervical Cancer Cells Through Up-regulation of MIF[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 468-474. DOI: 10.3971/j.issn.1000-8578.2018.17.1406
Citation: GE Caiyun, CAI Hongbing, SONG Ziye, LI Zhen, XU Mengfei. HPV16-E6 Influences Growth and Apoptosis of Cervical Cancer Cells Through Up-regulation of MIF[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 468-474. DOI: 10.3971/j.issn.1000-8578.2018.17.1406

HPV16-E6上调MIF对宫颈癌细胞增殖和凋亡的影响

HPV16-E6 Influences Growth and Apoptosis of Cervical Cancer Cells Through Up-regulation of MIF

  • 摘要:
    目的 检测人乳头瘤病毒16型的致癌基因E6(HPV16-E6)通过巨噬细胞移动抑制因子(MIF)对宫颈癌细胞增殖和凋亡的影响。
    方法 用HPV16-E6过表达和干扰质粒转染能分泌MIF的人宫颈癌细胞C33A、SiHa和Caski。Western blot和荧光定量PCR法检测MIF蛋白和mRNA表达,并用ELISA法检测培养上清液中MIF蛋白量;将转染后的宫颈癌细胞与人巨噬细胞非接触性共培养,检测巨噬细胞中MIF表达;C33A转染HPV16-E6后加或不加MIF抑制剂,CCK-8法和流式细胞术检测细胞增殖、周期和凋亡情况;采用Pearson相关分析法分析HPV16-E6和MIF间的关系、Kaplan-Meier分析HPV16-E6对患者生存率的影响。
    结果 癌细胞、上清液和巨噬细胞中MIF表达随HPV16-E6表达而上调(P < 0.05);HPV16-E6过表达可诱导C33A细胞增殖、减少G0/G1期细胞和抑制细胞凋亡;抑制MIF后,细胞增殖率下降、凋亡率增加(P < 0.05);HPV16-E6表达与MIF正相关(P < 0.05),Kaplan-Meier分析显示HPV16-E6表达与患者总生存率和无进展生存率有关(P < 0.05)。
    结论 HPV16-E6可诱导宫颈癌细胞及其微环境中巨噬细胞MIF表达,并可通过MIF诱导宫颈癌细胞增殖和抑制细胞凋亡而影响宫颈癌的预后。

     

    Abstract:
    Objective To investigate the effect of human papillomavirus oncogene E6(HPV16-E6) on the growth and apoptosis of cervical cancer cells via macrophage migration inhibitory factor(MIF).
    Methods Cervical cancer cells C33A, SiHa and Caski which could secrete MIF were transfected with HPV16-E6 overexpression vector or shRNA; Western blot, qRT-PCR and ELISA were used to examine MIF protein and mRNA expression and its supernatant. The cells above were co-cultured with human macrophages, and then we detected the expression of MIF in macrophages. MIF inhibitor was added or not in C33A group which was transfected with HPV16-E6; the cell proliferation, cell cycle and apoptosis were detected by CCK-8 method and flow cytometry. The association of HPV16-E6 expression with MIF and survival were analyzed using Pearson and Kaplan-Meier methods.
    Results The expression of MIF in cervical cancer cells, supernatant and macrophages were increased or decreased by up-regulation or down-regulation of HPV16-E6 expression(P < 0.05). HPV16-E6 over-expression could induce C33A cells proliferation, shorten G0/G1 phase and inhibit cell apoptosis, and these effects were reversed using MIF inhibitor(P < 0.05). There was positive correlation between HPV16-E6 expression and MIF in cervical cancer tissues(P < 0.05). Survival analysis suggested the expression of HPV16-E6 in cervical cancer tissues had a significant relationship with overall survival rate and progression-free survival rate(P < 0.05).
    Conclusion HPV16-E6 could induce the expression of MIF in cervical cancer cells and macrophages, promote the growth and inhibit the apoptosis of cervical cancer cells through up-regulation of MIF.

     

/

返回文章
返回